WallSt Focus
Total 474 Posts
SMCI Investigation Sparks Rally—Should Investors Be Concerned About Lingering Issues?
SMCI’s shares surged after an independent investigation found no evidence of fraud and the special committee's recommendation to strengthen governance has calmed some investor fears.
Stock Market Today: Stocks Wobble As Inflation Data Clouds Fed Rate Cut Bets
On Thursday, the stock market struggled for direction as new inflation data added uncertainty to the Federal Reserve's next policy move.
GM’s $1 Billion Stake Sale: Is the Carmaker Rethinking Its Battery Strategy?
GM has recently been in the news after it announced the sale of its stake in a $2.6 billion battery cell plant in Lansing, Michigan, to JV partner LG Energy Solution for approximately $1 billion.
October PCE Data Sparks Debate on Inflation Progress and Fed Policy
The October reading of the Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index, is giving mixed signals.
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
On December 3, 2024, the company announced groundbreaking results for its lead drug candidate, JANX007, a tumor-activated T-cell engager targeting advanced-stage prostate cancer.
Stock Market Today: Stocks Mixed Amid Fresh Jobs Data and Awaiting Fed Clarity
U.S. stocks were mixed on Tuesday as investors digested new job openings data and awaited future remarks from Federal Reserve officials.
Is MicroStrategy’s Bitcoin Frenzy Setting It Up For A Crash?
MicroStrategy has been making headlines once again, fueled by its audacious Bitcoin-centric strategy and a meteoric stock price rise of over 515% this year.